Call for Your FREE Evaluation (877) 503-1595

JAMA STATES THAT FDA TOO QUICK TO APPROVE PRADAXA

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

Fingolimod

JAMA STATES THAT FDA TOO QUICK TO APPROVE PRADAXA

Is the FDA’s push to approve drugs more quickly costing too much in the way of patient safety?  According to an article published in the Journal of the American Medical Association by two drug-safety experts, the answer is yes. They cite three drugs, including the controversial blood thinner Pradaxa, that were approved in an accelerated…..

Posted in Pharmaceutical and Medical Device News,
Tagged Blood Thinning Medication, Pradaxa, FDA, Caprelsa, Fingolimod, JAMA,